Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion.

A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion. PLoS Pathog. 2013; 9(4):e1003297.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.